Tranzactioneaza IPSEN (FR.IPN) - 113.1 EUR (%) Tranzactioneaza

1D
1W
1M
3M
6M
1Y
5Y
Max

Indici

Bid 113.5000 EUR
Ask 114.1000 EUR
Minim 112.4000 EUR
Maxim 113.1000 EUR
Pret referinta 115.1000
Volum -
Volum ultima zi 1
Max 52 sapt 126.7000 EUR
Min 52 sapt 99.7000 EUR

Descriere companie

Ipsen SA (www.ipsen.com) is a France-based biopharmaceutical group specialized in specialty care. The Company operates globally through two segments: Specialty Care and Consumer Healthcare. In Specialty Care, the Company is focused on various therapeutic areas, including oncology, neurosciences and rare diseases. Its oncology portfolio includes Somatuline, Decapeptyl, Cabometyx and Onivyde. Its neuroscience portfolio includes Dysport, and in rare diseases key products are NutropinAq and Increlex. Its primary care portfolio includes Smecta, Forlax, Fortrans, Eziclen, and Tanakan. In oncology Ipsen focuses on a number of disease areas, which include neuroendocrine tumors, renal cell carcinoma, hepatocellular carcinoma and pancreatic cancer. In addition, the Company has specialism in neurotoxin research and operates three research and development centers located in France, the United Kingdom and the United States.

Informatii companie

Nume

IPSEN